Zhejiang Hisun Pharmaceutical Co.Ltd.’s Net Profit Dropped 6.7% in First Three Quarters of 2021

Zhejiang Hisun Pharmaceutical Co.Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 557.1 million yuan in the first three quarters of 2021, down 6.7% year-on-year.

Meanwhile, the company posted 9.1 billion yuan in revenue, up 11.7% year-on-year.

At the end of the reporting period, it had 20 billion yuan in total assets and 12.5 billion yuan in total liabilities, with a liability-to-asset ratio of 62.5%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.